These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22441338)

  • 1. Use of nonprescription medicines by patients with COPD: a survey in Chongqing Municipality, China.
    Cao G; Li J; Li L; Li H; Wang F; Wang H; Zhang L
    Chron Respir Dis; 2012 May; 9(2):77-81. PubMed ID: 22441338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of medication and quality of life among patients with COPD.
    Esteban C; Moraza J; Quintana JM; Aburto M; Capelastegui A
    Respir Med; 2006 Mar; 100(3):487-95. PubMed ID: 16039840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patient' s perspective of chronic obstructive pulmonary disease in Yanqing county of Beijing].
    Shen N; Yao WZ; Zhu H
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Mar; 31(3):206-8. PubMed ID: 18785520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
    Zhang B; Zhang Y; Yang J; Liu X
    Wei Sheng Yan Jiu; 2007 Nov; 36(6):706-10. PubMed ID: 18303632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors influencing the use of health care services from patients with COPD in Chengdu].
    Zhang B; Zhang Y; Liu HC; Tian J; Tu GP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):316-20. PubMed ID: 17441359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S; Plauschinat CA; Wu N; Fraser K; Boulanger L
    J Med Econ; 2011; 14(4):458-62. PubMed ID: 21651427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation.
    Kunter E; Ilvan A; Ozmen N; Demirer E; Ozturk A; Avsar K; Sayan O; Kartaloğlu Z
    Respiration; 2008; 75(2):145-54. PubMed ID: 17143000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of chronic obstructive pulmonary disease on quality of life and economic burden in Chinese urban areas].
    He QY; Zhou X; Xie CM; Liang ZA; Chen P; Wu CG
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):253-7. PubMed ID: 19576036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The impact of socioeconomic status on the quality of life in patients with chronic obstructive pulmonary disease].
    Bak-Drabik K; Ziora D
    Pneumonol Alergol Pol; 2010; 78(1):3-13. PubMed ID: 20162513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are pharmacists reducing COPD'S impact through smoking cessation and assessing inhaled steroid use?
    Verma A; Harrison A; Torun P; Vestbo J; Edwards R; Thornton J
    Respir Med; 2012 Feb; 106(2):230-4. PubMed ID: 21899999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M; Smith CJ; Hubbard RB
    QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD.
    Wang Q; Bourbeau J
    Respirology; 2005 Jun; 10(3):334-40. PubMed ID: 15955146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes.
    Hernandez P; Balter M; Bourbeau J; Hodder R
    Respir Med; 2009 Jul; 103(7):1004-12. PubMed ID: 19269150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.